SERRE-YU WONG

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology NEW YORK, NY NPI 1730488305

General Payments — all program years on this page

$8,568.16

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 12
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $8,511.54 across 9 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $5,450.002
Food and Beverage $1,587.905
Travel and Lodging $1,473.642

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
E.R. Squibb & Sons, L.L.C. $6,023.643
Celgene Corporation $1,554.394
Takeda Pharmaceuticals U.S.A., Inc. $900.001
Lilly USA, LLC $33.511

By program year

Program yearAmountRecords
2022 $17.181
2023 $39.442
2024 $8,511.549

Records — PY2024 (9)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1101137360 Celgene Corporation $18.91 02/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101137362 Celgene Corporation $4.95 02/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101137364 Celgene Corporation $56.89 02/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101137376 Celgene Corporation $1,473.64 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101433997 E.R. Squibb & Sons, L.L.C. $276.21 03/14/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1101433999 E.R. Squibb & Sons, L.L.C. $1,197.43 03/14/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1101434005 E.R. Squibb & Sons, L.L.C. $4,550.00 04/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1135402935 Lilly USA, LLC $33.51 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137699406 Takeda Pharmaceuticals U.S.A., Inc. $900.00 02/27/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.